Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_assertion type Assertion NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_head.
- NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_assertion description "[Further understanding of the CXCR4/CXCL12 pathway in SCLC and NSCLC may provide a rationale for innovative research on the CXCR4 receptor as a potential novel therapeutic target in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_provenance.
- NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_assertion evidence source_evidence_literature NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_provenance.
- NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_assertion SIO_000772 20147779 NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_provenance.
- NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_assertion wasDerivedFrom befree-2016 NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_provenance.
- NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_assertion wasGeneratedBy ECO_0000203 NP793163.RA97UBJ3PutgQ2nhYM0j_vI7uLDJGoHwpWWuEVHSrPTZQ130_provenance.